NanoDrugs Journal

NanoDrugs is a new online only peer reviewed journal that accepts  articles  from all disciplines related to nanopharmacology and nanotoxicology.

URL: www.nanodrugs.org/journal

NanoDrugs  applies the Creative Commons Attribution License (CCAL) to all manuscripts to be published.

NanoDrugs accepts different type of Articles

• Case reports  (Peer reviewed)
• Editorials  (Non Peer reviewed)
• Educational Tecnologies  (Peer reviewed)
• Hypothesis  (Peer reviewed)
• Invited Review (and unsolicited)  (Peer reviewed)
• Mini-reviews (Peer reviewed)
• New Drug Update  (Peer reviewed)
• Original Research Articles (Peer reviewed)
• Short Communications (Peer reviewed)
• Technical Note (e.g., Methods & protocols) (Peer reviewed)
• White Paper  (Non-Peer reviewed) & Author's Brief (Non- Peer reviewed)
• Perspectives (Peer reviewed)

NanoDrugs offers fast peer-review and publication. Corresponding authors will receive a notification within 72 hrs that his/her manuscript is accepted or not for revision. All original articles submitted to NanoDrugs should be prepared according our journal style and will be reviewed within one month.

 

You own the copyrights: Authors who publish with NanoDrugs agree to the following terms: i). Authors retain copyright and grant NanoDrugs the right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. ii). Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. iii) Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.

Editorial Procedures

All manuscript submitted to NanoDrugs are critically assessed by external and/or inhouse experts (One of our Editorial Board Member that has knowledge of the field discussed in the manuscript) in accordance with the principles of Peer Review  http://www.icmje.org . This first step takes place entirely inhouse.

 

All manuscripts are sent for review. The reviewers will provide and extensive revision and a list of all critics authors need to address. If a manuscript does not receive a sufficiently high priority score to warrant publication, authors will be asked to provide a detailed resposne to all reviewers comments and resubmit their work within 3 month.

In the second step, the articles are reviewed by at least one editor and one external referees.

 

The third step is the decision step by the Editor-In-Chief or and associate editor.